Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03190408 · ClinicalTrials.gov registry record
Variation in Fluids Administered in Shock
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 1,639
- Enrollment target
NCT03190408: Completed study, sponsored by Montefiore Medical Center.
NCT03190408 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 1,639 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03190408 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 1,639 participants
- Enrollment target
Study Summary
To conduct a multicenter observational cohort study to determine the variability in fluid resuscitation in shock in a broad range of areas in hospitals and treatment areas.
Primary Outcome
Characterize the method used to guide volume resuscitation and vasopressor use in patients with shock
Interventions
- OTHER Fluids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,639 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2018-02-01 |
What the finished NCT03190408 record still lists
NCT03190408 is an observational study that tracks outcomes without assigning an intervention. Its 1,639 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Fluids is the first listed.
NCT03190408 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03190408 about?
NCT03190408 is a clinical study titled "Variation in Fluids Administered in Shock". To conduct a multicenter observational cohort study to determine the variability in fluid resuscitation in shock in a broad range of areas in hospitals and treatment areas.
What is the current status of trial NCT03190408?
This trial is currently completed. The enrollment target is 1,639 participants. The study started on 2017-09-01. Estimated completion is 2018-02-01.
What interventions are being tested in trial NCT03190408?
The interventions under investigation include: Fluids (OTHER).
Who is sponsoring clinical trial NCT03190408?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- NCT07046260 · 1,650 participants
Prospective Study to Assess a Diagnostic Aid for Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI